India permits clinical trial for nasal Covid booster shot

The central licensing authority (Drug Controller General of India) granted the permission for the world’s first nasal Covid shot as a booster

India permits clinical trial for nasal Covid booster shot

Photo for representation only. iStock

Tribune News Service

Aditi Tandon

New Delhi, January 28

India on Friday cleared Bharat Biotech’s intranasal Covid vaccine candidate for clinical trials as Covid booster dose.

The central licensing authority (Drug Controller General of India) granted the permission for the world’s first nasal Covid shot as a booster.

Once approved, this could be a game changer, sources said, citing the ease of vaccine delivery.

The permission to conduct clinical trials has been given for nine sites across India, including Pt BD Sharma Postgraduate Institute of Medical Sciences (PGIMS), UHS, Rothak, Haryana, AIIMS New Delhi and AIIMS Patna.

The candidate cleared for trials is Chimpanzee Adenovirus Vectored Covid Vaccine (BBV154).

#nasalbooster #nasalvaccine

Tribune Shorts


Top News

Survey under way at Gyanvapi Masjid complex for third day amid tight security

Gyanvapi Masjid survey concludes on third day amid tight security

Three court-appointed advocate commissioners, five lawyers e...

California churchgoers detained gunman in deadly attack; 1 dead, 5 hurt

California churchgoers detained gunman in deadly attack; 1 dead, 5 hurt

The shooting occurred during a lunch banquet after a morning...

Himachal police fail to locate phones of middlemen in constable paper leak case

Himachal police fail to locate phones of middlemen in constable paper leak case

Deliberate disappearance of evidence (cellphones) indicates ...

Cities

View All